稳定胸痛疑似冠心病女性和男性初始CT与有创冠状动脉造影的比较有效性:多中心随机试验
这项前瞻性多中心随机实用性试验在16个欧洲国家26家医院纳入3561例因稳定胸痛、阻塞性冠心病验前概率10-60%而转诊有创冠状动脉造影的患者(女性2002例,男性1559例),1:1随机接受初始CT或有创冠状动脉造影策略。中位随访3.5年,MACE无显著性别交互作用(P=0.29)。男性中初始CT组扩展MACE复合终点发生率低于有创冠状动脉造影组(2.8% vs 5.3%;HR 0.52,95%CI 0.31-0.87);女性中初始CT组重大手术相关并发症风险低于有创冠状动脉造影组(0.3% vs 2.1%;HR 0.14,95%CI 0.04-0.46)。结论认为女性和男性从初始CT策略中获益无差异证据。
要点
- 女性中初始CT组重大手术相关并发症3例(0.3%) vs 有创冠状动脉造影组21例(2.1%),HR 0.14(95%CI 0.04-0.46)。
- 男性中初始CT组扩展MACE复合终点22例(2.8%) vs 有创冠状动脉造影组41例(5.3%),HR 0.52(95%CI 0.31-0.87)。
- MACE性别交互作用P=0.29,扩展MACE复合终点P=0.45,重大手术相关并发症P=0.11,均无统计学显著性别交互作用。
- 两性别中初始CT组与有创冠状动脉造影组MACE发生率均无差异。
- 适用人群为稳定胸痛、阻塞性冠心病验前概率10-60%、拟行有创冠状动脉造影者。
适用人群与场景
- 因稳定胸痛、阻塞性冠心病验前概率10-60%而转诊有创冠状动脉造影的患者,共3561例(女性2002例,男性1559例)。
处置流程与药物剂量
- 女性和男性均1:1随机(按性别和中心分层)接受初始CT或有创冠状动脉造影策略作为初始诊断检查:女性分别为1019例和983例,男性分别为789例和770例;按意向性治疗分析。
研究设计与关键结果
- 前瞻性、多中心、随机实用性试验,16个欧洲国家26家医院,纳入3561例(女性2002例,男性1559例)。
- 中位随访3.5年,女性98.9%(1979/2002)、男性99.0%(1544/1559)可获取随访。
- MACE(心血管死亡、非致死性心肌梗死或非致死性卒中)性别交互作用P=0.29;扩展MACE复合终点(心血管死亡、非致死性心肌梗死、非致死性卒中、短暂性脑缺血发作或重大手术相关并发症)P=0.45;重大手术相关并发症P=0.11。
- 两性别中初始CT组与有创冠状动脉造影组MACE发生率均无差异。
- 男性中扩展MACE复合终点初始CT组22例(2.8%) vs 有创冠状动脉造影组41例(5.3%),HR 0.52(95%CI 0.31-0.87)。
- 女性中重大手术相关并发症初始CT组3例(0.3%) vs 有创冠状动脉造影组21例(2.1%),HR 0.14(95%CI 0.04-0.46)。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、随机实用性试验(RCT)。
- 随机分配无法设盲,但结局由对随机分组设盲的研究者评估。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于稳定胸痛、阻塞性冠心病验前概率10-60%的患者,初始CT策略与有创冠状动脉造影相比,在男性中与扩展MACE复合终点发生频率更低相关(2.8% vs 5.3%;HR 0.52,95%CI 0.31-0.87),在女性中与重大手术相关并发症风险更低相关(0.3% vs 2.1%;HR 0.14,95%CI 0.04-0.46)。
- 作者认为,女性和男性从使用CT而非有创冠状动脉造影作为初始诊断检查中的获益无差异证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the comparative effectiveness of computed tomography and invasive coronary angiography in women and men with stable chest pain suspected to be caused by coronary artery disease.
DESIGN: Prospective, multicentre, randomised pragmatic trial.
SETTING: Hospitals at 26 sites in 16 European countries.
PARTICIPANTS: 2002 (56.2%) women and 1559 (43.8%) men (total of 3561 patients) with suspected coronary artery disease referred for invasive coronary angiography on the basis of stable chest pain and a pre-test probability of obstructive coronary artery disease of 10-60%.
INTERVENTION: Both women and men were randomised 1:1 (with stratification by gender and centre) to a strategy of either computed tomography or invasive coronary angiography as the initial diagnostic test (1019 and 983 women, and 789 and 770 men, respectively), and an intention-to-treat analysis was performed. Randomised allocation could not be blinded, but outcomes were assessed by investigators blinded to randomisation group.
MAIN OUTCOME MEASURES: The primary endpoint was major adverse cardiovascular events (MACE; cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke). Key secondary endpoints were an expanded MACE composite (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, transient ischaemic attack, or major procedure related complication) and major procedure related complications.
RESULTS: Follow-up at a median of 3.5 years was available in 98.9% (1979/2002) of women and in 99.0% (1544/1559) of men. No statistically significant gender interaction was found for MACE (P=0.29), the expanded MACE composite (P=0.45), or major procedure related complications (P=0.11). In both genders, the rate of MACE did not differ between the computed tomography and invasive coronary angiography groups. In men, the expanded MACE composite endpoint occurred less frequently in the computed tomography group than in the invasive coronary angiography group (22 (2.8%) v 41 (5.3%); hazard ratio 0.52, 95% confidence interval 0.31 to 0.87). In women, the risk of having a major procedure related complication was lower in the computed tomography group than in the invasive coronary angiography group (3 (0.3%) v 21 (2.1%); hazard ratio 0.14, 0.04 to 0.46).
CONCLUSION: This study found no evidence for a difference between women and men in the benefit of using computed tomography rather than invasive coronary angiography as the initial diagnostic test for the management of stable chest pain in patients with an intermediate pre-test probability of coronary artery disease. An initial computed tomography scan was associated with fewer major procedure related complications in women and a lower frequency of the expanded MACE composite in men.
TRIAL REGISTRATION: NCT02400229ClinicalTrials.gov NCT02400229.
参考来源
- Kofoed KF, Bosserdt M, Maurovich-Horvat P, et al. Comparative effectiveness of initial computed tomography and invasive coronary angiography in women and men with stable chest pain and suspected coronary artery disease: multicentre randomised trial. BMJ. 2022. PMID: 36261169. doi:10.1136/bmj-2022-071133
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。